Aimei Health Technology Co., Ltd.
Aimei Health Technology Co., Ltd.
Aimei Health Technology Co., Ltd. (AFJK) — SEC Financial Statements & Analysis
Aimei Health Technology Co., Ltd. (AFJK) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Assets Current | |||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Prepaid Expense Current | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Other Receivables | - | - | - | - | - | - | - | - | 0 | - | |||||
Assets Held In Trust Noncurrent | 12 | 12 | 45 | 45 | 44 | 74 | 73 | 72 | 71 | 70 | |||||
Assets | 12 | 12 | 45 | 45 | 44 | 74 | 73 | 72 | 71 | 70 | |||||
Liabilities And Stockhold… | |||||||||||||||
Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | |||||||||||||||
Liabilities Current | 4 | 3 | 3 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | |||||
Other Short Term Borrowings | 2 | 2 | 2 | 1 | 1 | 0 | - | - | - | - | |||||
Other Liabilities Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | - | - | |||||
Redeemable Noncontrolling… | |||||||||||||||
Deferred Compensation Liability Classified Noncurr… | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities | 4 | 4 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | |||||
Temporary Equity Carrying Amount Attributable To P… | 12 | 12 | 45 | 45 | 44 | 74 | 73 | 72 | 71 | 70 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||
Stockholders Equity | -4 | -4 | -3 | -3 | -2 | -1 | -1 | -1 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -4 | -4 | -3 | -3 | -2 | -1 | -1 | -1 | -0 | -0 | |||||
Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | 0 | |||||
Temporary Equity Shares Authorized | - | - | - | - | - | - | - | - | - | 500 | |||||
Liabilities And Stockholders Equity | 12 | 12 | 45 | 45 | 44 | 74 | 73 | 72 | 71 | 70 | |||||
Temporary Equity Shares Issued | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | |||||
Temporary Equity Shares Outstanding | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | |||||
Temporary Equity Redemption Price Per Share | 11.8 | 11.63 | 11.37 | 11.14 | 10.91 | 10.69 | 10.53 | 10.39 | 10.26 | 10.13 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Shares Outstanding | 4 | 4 | 4 | 4 | 2 | 6 | 6 | 6 | 6 | 6 | |||||
Shares Subject To Mandatory Redemption Settlement … | 1 | 1 | 4 | 4 | 4 | 7 | 7 | 7 | 7 | 7 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -60.36% | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | 1.09% | 1.09% | 2.45% | 0.36% | 1.07% | 2.05% | 182.03% | 537.64% | 360.65% | -3.45% | -38.37% | - |
| 2024 | 0.19% | 0.61% | 0.78% | 0.38% | 0.77% | 1.15% | -0.39% | 0.37% | 1.02% | -0.06% | 1.39% | 1.39% |
| 2023 | - | - | - | - | - | - | - | - | - | 0.79% | 1.18% | 2.73% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data